INCIDENCE OF THROMBOEMBOLIC EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS, PSORIASIS, PSORIATIC ARTHRITIS AND ULCERATIVE COLITIS DEVELOPMENT PROGRAMMES

被引:3
|
作者
Mease, P. J. [1 ,2 ]
Kremer, J. [3 ]
Cohen, S. [4 ]
Curtis, J. R. [5 ]
Charles-Schoeman, C. [6 ]
Loftus, E. V., Jr. [7 ]
Greenberg, J. [8 ]
Palmetto, N. [7 ]
Kanik, K. S. [10 ]
Graham, D. [10 ]
Wang, C. [10 ]
Biswas, P. [9 ]
Chan, G. [11 ]
DeMasi, R. [11 ]
Valdez, H. [9 ]
Hendrikx, T. [11 ]
Jones, T. V. [11 ]
机构
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Albany Med Coll & Ctr Rheumatol, Albany, NY USA
[4] Metroplex Clin Res Ctr, Dallas, TX USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Mayo Clin, Rochester, MN USA
[8] Corrona LLC, Southborough, MA USA
[9] Pfizer Inc, New York, NY USA
[10] Pfizer Inc, Groton, CT 06340 USA
[11] Pfizer Inc, Collegeville, PA USA
关键词
D O I
10.1136/annrheumdis-2018-eular.3048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0243
引用
收藏
页码:983 / 983
页数:1
相关论文
共 50 条
  • [41] Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
    Solomon, Daniel H.
    Love, Thorvardur Jon
    Canning, Claire
    Schneeweiss, Sebastian
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) : 2114 - 2117
  • [42] Pharmacologic Immunomodulation and Cutaneous Malignancy in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis
    Krathen, Michael S.
    Gottlieb, Alice B.
    Mease, Philip J.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) : 2205 - 2215
  • [43] Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Ogdie, Alexis
    de Vlam, Kurt
    McInnes, Iain B.
    Mease, Philip J.
    Baer, Philip
    Lukic, Tatjana
    Gruben, David
    Kwok, Kenneth
    Wang, Cunshan
    Hsu, Ming-Ann
    Maniccia, Anna
    RMD OPEN, 2020, 6 (01):
  • [44] EFFECT OF TOFACITINIB ON REDUCING PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ogdie, A.
    de Vlam, K.
    McInnes, I. B.
    Mease, P. J.
    Baer, P.
    Lukic, T.
    Kwok, K.
    Wang, C.
    Hsu, M. -A.
    Maniccia, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 971 - 972
  • [45] Effect of Tofacitinib on Reducing Pain in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
    Ogdie, Alexis
    de Vlam, Kurt
    McInnes, Iain B.
    Mease, Philip J.
    Baer, Philip
    Lukic, Tatjana
    Kwok, Kenneth
    Wang, Cunshan
    Hsu, Ming-Ann
    Maniccia, Anna
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] Impact of Abbvie's Patient Support Program on Resource Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Rubin, David T.
    Skup, Martha
    Davis, Matthew
    Johnson, Scott
    Chao, Jingdong
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] Use of Tofacitinib for the Treatment of Arthritis Associated With Vedolizumab in Ulcerative Colitis
    Rubin, David T.
    Cleveland, Noa Krugliak
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1098 - S1099
  • [49] Impact of DMARD Treatment on Risk of Repeat Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis
    Sparks, Jeffrey A.
    Lesperance, Tamara
    Accortt, Neil A.
    Solomon, Daniel H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [50] Liaison between rheumatoid arthritis and ulcerative colitis
    Aydin, Y
    Özçakar, L
    Yidiz, M
    Akinci, A
    RHEUMATOLOGY INTERNATIONAL, 2003, 23 (01) : 47 - 48